Surgical management in metastatic squamous cell carcinoma of the larynx to the cavernous sinus. Case report
DOI:
https://doi.org/10.23938/ASSN.0289Keywords:
Cavernous sinus Brain metastases. Squamous carcinoma. Larynx.Abstract
The spread to the cavernous sinus in laryngeal cancer means the presence of a disseminated disease and short survival. The aim of this paper is to report a case of laryngeal squamous carcinoma of the larynx.
A search was conducted in the databases of Medline and SciELO DOYMA using the words "cavernous sinus metastasis”. We found 10 published cases of laryngeal squamous carcinoma with metastasis to the cavernous sinus.
The average survival of the 10 cases reported in the literature was 4.1 months; in our case it was 9 months. Patients who received radiotherapy improved symptomatically. In some cases the diagnosis was confirmed only after necropsy.
In this type of lesions, surgery is used for diagnosis rather than as a therapeutic tool.
Downloads
References
1. DE BREE R, MEHTA DM, SNOW GB, QUAK JJ. Intracranial metastases in patients with squamous cell carcinoma of the head and Neck Otolaryngol Head Neck. 2001; 124: 217-221.
https://doi.org/10.1067/mhn.2001.112478
2. ZAHRA M, TEWFIK HH, MCCABE BF. Metastases to the cavernous sinus from primary carcinoma of the larynx. J Laryngol Otol 1986; 31: 69-70.
https://doi.org/10.1002/jso.2930310117
3. TRASERRA J, COMAS J, CONDE C, CUCHI A, CARDESA A. Metastatic involvement of the cavernous sinus from primary pharyngolaryngeal tumors. Head Neck 1990; 12: 426-429.
https://doi.org/10.1002/hed.2880120510
4. CURRY MP, NEWLON JL, WATSON DW. Cavernous sinus metastasis from laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2001; 125: 567-568.
https://doi.org/10.1067/mhn.2001.116781
5. BUMPOUS JM, MAVES MD, GÓMEZ SM, LEVY BK, JOHNSON F. Cavernous sinus involvement in head and neck cancer. Head Neck 1993; 15: 62-66.
https://doi.org/10.1002/hed.2880150114
6. AHMAD K, KIM YH, POST MJ, BYUN Y, FAYOS JV. Hematogenous neoplastic spread to the cavernous sinus: report of a case. Int J Radiat Oncol Biol Phys 1984; 10: 321.
https://doi.org/10.1016/0360-3016(84)90020-8
7. KATTAH JC, SILGALS RM, MANZ H, TORO JG, DRITSCHILO A, SMITH FP. Presentation and management of parasellar and suprasellar metastatic mass lesions. J Neurol Neurosurg Psychiatry 1985; 48: 44-49.
https://doi.org/10.1136/jnnp.48.1.44
8. THOMAS JE, YOSS RE. The parasellar syndrome: problems in determining etiology. Mayo Clin Proc 1970; 45: 617-623.
https://doi.org/10.1109/PROC.1970.7718
9. GONZÁLEZ GARCÍA R, SASTRE PÉREZ J, NAVAL GIAS L, RODRÍGUEZ CAMPO FJ, DÍAZ GONZÁLEZ FJ. Cavernous sinus metastasis from oropharyngeal squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2007; 12: E166-170.
10. SMITH JK. Parasellar tumors: suprasellar and cavernous sinuses. Top Magn Reson Imaging 2005; 16: 307-315.
https://doi.org/10.1097/01.rmr.0000224687.29371.9a
11. PICKREN JW, LOPEZ G, TSUKADA Y, LANE WW. Brain metastases: an autopsy study. Cancer Treat Symp 1983; 13: 295-313.
12. MESSERER M, DUBOURG J, SAINT-PIERRE G, JOUANNEAU E, SINDOU M. Percutaneous biopsy of lesions in the cavernous sinus region through the foramen ovale: diagnostic accuracy and limits in 50 patients. J Neurosurg 2012; 116: 390-398.
https://doi.org/10.3171/2011.10.JNS11783
13. AL-MEFTY O, SMITH RR. Surgery of tumors invading the cavernous sinus. Surg Neurol 1988; 30: 370-381.
https://doi.org/10.1016/0090-3019(88)90200-5
14. SEKHAR LN, POMERANZ S, SEN CN. Management of tumours involving the cavernous sinus. Acta Neurochir Suppl (Wien) 1991; 53: 101-112.
https://doi.org/10.1007/978-3-7091-9183-5_18
15. VIKRAM B, CHU FC. Radiation therapy for metastases to the base of the skull. Radiology 1979; 130: 465-468.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
